Formation Bio, Sanofi and OpenAI launched Muse, an AI tool to speed clinical trial patient recruitment, starting in Phase 3 MS studies.

Patient recruitment is slow and costly, with fewer than 10% of eligible patients participating. Muse condenses recruitment strategy and content creation from months to minutes. Sanofi plans to roll it out first in Phase 3 multiple sclerosis studies; the page gives no measured outcomes.

Formation Bio is an AI and technology driven drug developer that builds tools such as Muse with Sanofi and OpenAI to speed clinical development

This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.